The redox regulation of PI 3-kinase-dependent signaling

Antioxidants and Redox Signaling

Volumn 8, Issue 9-10, 2006, Pages 1765-1774

  Leslie, Nick R ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GROWTH FACTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; PROTEIN TYROSINE PHOSPHATASE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE;

CELL GROWTH; CELL MOTILITY; CELL PROLIFERATION; CELL SURVIVAL; DIABETES MELLITUS; ENZYME ACTIVATION; ENZYME INACTIVATION; ENZYME INHIBITION; ENZYME MECHANISM; ENZYME REGULATION; HUMAN; INSULIN RESISTANCE; NITROSYLATION; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; HUMANS; MODELS, BIOLOGICAL; OXIDATION-REDUCTION; PROTEIN-TYROSINE-PHOSPHATASE; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 33750906556     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2006.8.1765     Document Type: Review

References (87)

1. Adler V, Yin Z, Fuchs SY, Benezra M, Rosario L, Tew KD, Pincus MR, Sardana M, Henderson CJ, Wolf CR, Davis RJ, and Ronai Z. Regulation of JNK signaling by GSTp. EMBO J 18: 1321-1334, 1999.
2. Alonso A, Sasin J, Bottini N, Friedberg I, Osterman A, Godzik A, Hunter T, Dixon J, and Mustelin T. Protein tyrosine phosphatases in the human genome. Cell 117: 699-711, 2004.
3. Andersen JN, Jansen PG, Echwald SM, Mortensen OH, Fukada T, Del Vecchio R, Tonks NK, and Moller NP. A genomic perspective on protein tyrosine phosphatases: gene structure, pseudogenes, and genetic disease linkage. FASEB J 18: 8-30 2004.
4. Bae YS, Kang SW, Seo MS, Baines IC, Tekle E, Chock PB, and Rhee SG. Epidermal growth factor (EGF)-induced generation of hydrogen peroxide. Role in EGF receptor-mediated tyrosine phosphorylation. J Biol Chem 272: 217-221, 1997.
5. Cantley LC. The phosphoinositide 3-kinase pathway. Science 296: 1655-1657, 2002.
6. Cantrell DA. Phosphoinositide 3-kinase signaling pathways. J Cell Sci 114: 1439-1445, 2001.
7. Carvalho-Filho MA, Ueno M, Hirabara SM, Seabra AB, Carvalheira JB, de Oliveira MG, Velloso LA, Curi R, and Saad MJ. 5-nitrosation of the insulin receptor, insulin receptor substrate 1, and protein kinase B/Akt: a novel mechanism of insulin resistance. Diabetes 54: 959-967, 2005.
8. Chen Q, Olashaw N, and Wu J. Participation of reactive oxygen species in the lysophosphatidic acid-stimulated mitogen-activated protein kinase kinase activation pathway. J Biol Chem 270: 28499-28502, 1995.
9. Chiarugi P and Cirri P. Redox regulation of protein tyrosine phosphatases during receptor tyrosine kinase signal transduction. Trends Biochem Sci 28: 509-514, 2003.
10. Choi MH, Lee IK, Kim GW, Kim BU, Han YH, Yu DY, Park HS, Kim KY, Lee JS, Choi C, Bae YS, Lee BI, Rhee SG, and Kang SW. Regulation of PDGF signaling and vascular remodelling by peroxiredoxin II. Nature 435: 347-353, 2005.
11. Connor KM, Subbaram S, Regan KJ, Nelson KK, Mazurkiewicz JE, Bartholomew PJ, Aplin AE, Tai YT, Aguirre-Ghiso J, Flores SC, and Melendez JA. Mitochondrial H2O2 regulates the angiogenic phenotype via PTEN oxidation. J Biol Chem 280: 16916-16924, 2005.
12. Dames SA, Mulet JM, Rathgeb-Szabo K, Hall MN, and Grzesiek S. The solution structure of the FATC domain of the protein kinase target of rapamycin suggests a role for redox-dependent structural and cellular stability. J Biol Chem 280: 20558-20564, 2005.
13. Denu JM and Tanner KG. Specific and reversible inactivation of protein tyrosine phosphatases by hydrogen peroxide: evidence for a sulfenic acid intermediate and implications for redox regulation. Biochemistry 37: 533-542, 1998.
14. Droge W. Free radicals in the physiological control of cell function. Physiol Rev 82: 47-95, 2002.
15. Dyson JM, Kong AM, Wiradjaja F, Astle MV, Gurung R, and Mitchell CA. The SH2 domain containing inositol polyphosphate 5-phosphatase-2: SHIP2. Int J Biochem Cell Biol 37: 2260-2265, 2005.
16. el-Remessy AB, Bartoli M, Platt DH, Fulton D, and Caldwell RB. Oxidative stress inactivates VEGF survival signaling in retinal endothelial cells via PI 3-kinase tyrosine nitration. J Cell Sci 118: 243-252, 2005.
17. Evans JL, Goldfine ID, Maddux BA and Grodsky GM. Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction? Diabetes 52: 1-8, 2003.
18. Finkel T. Redox-dependent signal transduction. FEBS Lett 476: 52-54 2000.
19. Frank GD, Eguchi S, and Motley ED. The role of reactive oxygen species in insulin signaling in the vasculature. Antioxid Redox Signal 7: 1053-1061, 2005.
20. Fratelli M, Demol H, Puype M, Casagrande S, Eberini I, Salmona M, Bonetto V, Mengozzi M, Duffieux F, Miclet E, Bachi A, Vandekerckhove J, Gianazza E, and Ghezzi P. Identification by redox proteomics of glutathionylated proteins in oxidatively stressed human T lymphocytes. Proc Natl Acad Sci USA 99: 3505-3510, 2002.
21. Goldstein BJ, Mahadev K, and Wu X. Redox paradox: insulin action is facilitated by insulin-stimulated reactive oxygen species with multiple potential signaling targets. Diabetes 54: 311-321, 2005.
22. Griendling KK, Minieri CA, Ollerenshaw JD, and Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 74: 1141-1148, 1994.
23. Halstead JR, Roefs M, Ellson CD, D'Andrea S, Chen C, D'Santos CS, and Divecha N. A novel pathway of cellular phosphatidylinositol(3,4,5)-trisphosphate synthesis is regulated by oxidative stress. Curr Biol 11: 386-395, 2001.
24. Hanson GT, Aggeler R, Oglesbee D, Cannon M, Capaldi RA, Tsien RY, and Remington SJ. Investigating mitochondrial redox potential with redox-sensitive green fluorescent protein indicators. J Biol Chem 279: 13044-13053, 2004.
25. Harfouche R, Abdel-Malak NA, Brandes RP, Karsan A, Irani K, and Hussain SN. Roles of reactive oxygen species in angiopoietin-1/tie-2 receptor signaling. FASEB J 19: 1728-1730, 2005.
26. Huang X., Begley M, Morgenstern KA, Gu Y, Rose P, Zhao H, and Zhu X. Crystal structure of an inactive Akt2 kinase domain. Structure (Camb) 11: 21-30, 2003.
27. Irani K, Xia Y, Zweier JL, Sollott SJ, Der CJ, Fearon ER, Sundaresan M, Finkel T, and Goldschmidt-Clermont PJ. Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science 275: 1649-1652, 1997.
28. Kamata H, Honda S, Maeda S, Chang L, Hirata H, and Karin M. Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 120: 649-661, 2005.
29. Kaneto H, Kawamori D, Nakatani Y, Gorogawa S, and Matsuoka TA. Oxidative stress and the JNK pathway as a potential therapeutic target for diabetes. Drug News Perspect 17: 447-453, 2004.
30. Katso R, Okkenhaug K, Ahmadi K, White S, Timms J, and Waterfield MD. Cellular function of phosphoinositide 3-kinases: implications for development, homeostasis, and cancer. Annu Rev Cell Dev Biol 17: 615-675, 2001.
31. Kenyon C. The plasticity of aging: insights from long-lived mutants. Cell 120: 449-460, 2005.
32. Klotz LO, Schieke SM, Sies H, and Holbrook NJ. Peroxynitrite activates the phosphoinositide 3-kinase/Akt pathway in human skin primary fibroblasts. Biochem J 352: 219-225, 2000.
33. Konishi H, Matsuzaki H, Tanaka M, Takemura Y, Kuroda S, Ono Y, and Kikkawa U. Activation of protein kinase B (Akt/RAC-protein kinase) by cellular stress and its association with heat shock protein Hsp27. FEBS Lett 410: 493-498, 1997.
34. Kops GJ, Dansen TB, Polderman PE, Saarloos I, Wirtz KW, Coffer PJ, Huang TT, Bos JL, Medema RH, and Burgering BM. Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature 419: 316-321, 2002.
35. Krieger-Brauer HI and Kather H. Antagonistic effects of different members of the fibroblast and platelet-derived growth factor families on adipose conversion and NADPH-dependent H2O2 generation in 3T3 L1-cells. Biochem J 307: 549-556, 1995.
36. Krieger-Brauer HI and Kather H. Human fat cells possess a plasma membrane-bound H2O2-generating system that is activated by insulin via a mechanism bypassing the receptor kinase. J Clin Invest 89: 1006-1013, 1992.
37. Kuroki M, Voest EE, Amano S, Beerepoot LV, Takashima S, Tolentino M, Kim RY, Rohan RM, Colby KA, Yeo KT, and Adamis AP. Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo. J Clin Invest 98: 1667-1675, 1996.
38. Kwon J, Lee SR, Yang KS, Ann Y, Kim YJ, Stadtman ER, and Rhee SG. Reversible oxidation and inactivation of the tumor suppressor PTEN in cells stimulated with peptide growth factors. Proc Natl Acad Sci USA 101: 16419-16424, 2004.
39. Kwon J, Qu CK, Maeng JS, Falahati R, Lee C, and Williams MS. Receptor-stimulated oxidation of SHP-2 promotes T-cell adhesion through SLP-76-ADAP. EMBO J 24: 2331-2341, 2005.
40. Lawlor MA and Alessi DR. PKB/Akt: a key mediator of cell proliferation, survival and insulin responses? J Cell Sci 114: 2903-2910, 2001.
41. Lee SR, Kwon KS, Kim SR, and Rhee SG. Reversible inactivation of protein-tyrosine phosphatase 1B in A431 cells stimulated with epidermal growth factor. J Biol Chem 273: 15366-15372, 1998.
42. Lee SR, Yang KS, Kwon J, Lee C, Jeong W, and Rhee SG. Reversible inactivation of the tumor suppressor PTEN by H2O2. J Biol Chem 277: 20336-20342, 2002.
43. Leslie NR, Bennett D, Lindsay YE, Stewart H, Gray A, and Downes CP. Redox regulation of PI 3-kinase signaling via inactivation of PTEN. EMBO J 22: 5501-5510, 2003.
44. Leslie NR and Downes CP. PTEN: The down side of PI 3-kinase signaling. Cell Signal 14: 285-295, 2002.
45. Leslie NR, Lindsay Y, Ross SH, and Downes CP. Redox regulation of phosphatase function. Biochem Soc Trans 32: 1018-1020, 2004.
46. Lo YY and Cruz TF. Involvement of reactive oxygen species in cytokine and growth factor induction of c-fos expression in chondrocytes. J Biol Chem 270: 11727-11730, 1995.
47. Maddux BA, See W, Lawrence JC Jr, Goldfine AL, Goldfine ID, and Evans JL. Protection against oxidative stress-induced insulin resistance in rat L6 muscle cells by micromolar concentrations of alpha-lipoic acid. Diabetes 50: 404-410, 2001.
48. Mahadev K, Wu X, Zilbering A, Zhu L, Lawrence JT, and Goldstein BI. Hydrogen peroxide generated during cellular insulin stimulation is integral to activation of the distal insulin signaling cascade in 3T3-L1 adipocytes. J Biol Chem 276: 48662-48669, 2001.
49. Mahadev K, Zilbering A, Zhu L, and Goldstein BJ. Insulin-stimulated hydrogen peroxide reversibly inhibits protein-tyrosine phosphatase 1b in vivo and enhances the early insulin action cascade. J Biol Chem 276: 21938-21942, 2001.
50. Martin D, Salinas M, Fujita N, Tsuruo T, and Cuadrado A. Ceramide and reactive oxygen species generated by H2O2 induce caspase-3-independent degradation of Akt/protein kinase B. J Biol Chem 277: 42943-42952, 2002.
51. Maulik N. Redox signaling of angiogenesis. Antioxid Redox Signal 4: 805-815, 2002.
52. McManus EJ and Alessi DR. TSC1-TSC2: a complex tale of PKB-mediated S6K regulation. Nat Cell Biol 4: E214-E216, 2002.
53. Medina EA, Afsari RR, Ravid T, Castillo SS, Erickson KL, and Goldkorn T. Tumor necrosis factor-{alpha} decreases Akt protein levels in 3T3-L1 adipocytes via the caspase-dependent ubiquitination of Akt. Endocrinology 146: 2726-2735, 2005.
54. Meier B, Radeke HH, Selle S, Younes M, Sies H, Resch K, and Habermehl GG. Human fibroblasts release reactive oxygen species in response to interleukin-1 or tumor necrosis factor-alpha. Biochem J 263: 539-545, 1989.
55. Meng TC, Buckley DA, Galic S, Tiganis T, and Tonks NK. Regulation of insulin signaling through reversible oxidation of the protein tyrosine phosphatases TC45 and PTP1B. J Biol Chem 279: 37716-37725, 2004.
56. Meng TC, Fukada T, and Tonks NK. Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo. Mol Cell 9: 387-399, 2002.
57. Mitra P, Zhang Y, Rameh LE, Ivshina MP, McCollum D, Nunnari JJ, Hendricks GM, Kerr ML, Field SJ, Cantley LC, and Ross AH. A novel phosphatidylinositol(3, 4,5)P3 pathway in fission yeast. J Cell Biol 166: 205-211, 2004.
58. Murata H, Ihara Y, Nakamura H, Yodoi J, Sumikawa K, and Kondo T. Glutaredoxin exerts an antiapoptotic effect by regulating the redox state of Akt. J Biol Chem 278: 50226-50233, 2003.
59. Nemoto S and Finkel T. Redox regulation of forkhead proteins through a p66shc-dependent signaling pathway. Science 295: 2450-2452, 2002.
60. Paron I, D'Elia A, D'Ambrosio C, Scaloni A, D'Aurizio F, Prescott A, Damante G, and Tell G. A proteomic approach to identify early molecular targets of oxidative stress in human epithelial lens cells. Biochem J 378: 929-937, 2004.
61. Perreault M and Marette A. Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle. Nat Med 7: 1138-1143, 2001.
62. Rhee SG. Redox signaling: hydrogen peroxide as intracellular messenger. Exp Mol Med 31: 53-59, 1999.
63. Rhee SG, Kang SW, Jeong W, Chang TS, Yang KS, and Woo HA. Intracellular messenger function of hydrogen peroxide and its regulation by peroxiredoxins. Curr Opin Cell Biol 17: 183-189, 2005.
64. Salmeen A and Barford D. Functions and mechanisms of redox regulation of cysteine-based phosphatases. Antioxid Redox Signal 1: 560-677, 2005.
65. Sarbassov DD, Guertin DA, Ali SM, and Sabatini DM. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307: 1098-1101, 2005.
66. Saurin AT, Neubert H, Brennan JP, and Eaton P. Widespread sulfenic acid formation in tissues in response to hydrogen peroxide. Proc Natl Acad Sci USA 101: 17982-17987, 2004.
67. Scott JA and King GL. Oxidative stress and antioxidant treatment in diabetes. Ann NY Acad Sci 1031: 204-213, 2004.
68. Seminario MC and Wange RL. Signaling pathways of D3-phosphoinositide- binding kinases in T cells and their regulation by PTEN. Semin Immunol 14: 27-36, 2002
69. Seo JH, Ahn Y, Lee SR, Yeol Yeo C, and Chung Hur K. The major target of the endogenously generated reactive oxygen species in response to insulin stimulation is phosphatase and tensin homolog and not phosphoinositide-3 kinase (PI-3 kinase) in the PI-3 kinase/Akt pathway. Mol Biol Cell 16: 348-357, 2005.
70. Shaw M, Cohen P, and Alessi DR. The activation of protein kinase B by H2O2 or heat shock is mediated by phosphoinositide 3-kinase and not by mitogen-activated protein kinase-activated protein kinase-2. Biochem J 336: 241-246, 1998.
71. Stephens L, Williams R, and Hawkins P. Phosphoinositide 3-kinases as drug targets in cancer. Curr Opin Pharmacol 5: 357-365, 2005.
72. Stone RL and Dixon JE. Protein-tyrosine phosphatases. J Biol Chem 269: 31323-31326, 1994.
73. Suire S, Coadwell J, Ferguson GJ, Davidson K, Hawkins P, and Stephens L. p84, a new Gbetagamma-activated regulatory subunit of the type IB phosphoinositide 3-kinase p110gamma. Curr Biol 15: 566-570, 2005.
74. Sulis ML and Parsons R. PTEN: from pathology to biology. Trends Cell Biol 13: 478-483, 2003.
75. Sundaresan M, Yu ZX, Ferrans VJ, Irani K, and Finkel T. Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science 270: 296-269, 1995.
76. Takeda K, Matsuzawa A, Nishitoh H, and Ichijo H. Roles of MAPKKK ASK1 in stress-induced cell death. Cell Struct Funct 28: 23-29, 2003.
77. Tonks NK. Redox redux: revisiting PTPs and the control of cell signaling. Cell 121: 667-670, 2005.
78. Ushio-Fukai M, Alexander RW, Akers M, Yin Q, Fujio Y, Walsh K, and Griendling KK. Reactive oxygen species mediate the activation of Akt/protein kinase B by angiotensin II in vascular smooth muscle cells. J Biol Chem 274: 22699-22704, 1999.
79. Van der Kaay J, Beck M, Gray A, and Downes CP. Distinct phosphatidylinositol 3-kinase lipid products accumulate upon oxidative and osmotic stress and lead to different cellular responses. J Biol Chem 274: 35963-35968, 1999.
80. Vanhaesebroeck B, Leevers SJ, Ahmadi K, Timms J, Katso R, Driscoll PC, Woscholski R, Parker PJ, and Waterfield MD. Synthesis and function of 3-phosphorylated inositol lipids. Annu Rev Biochem 70: 535-602, 2001.
81. Vivanco I and Sawyers CL. The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat Rev Cancer 2: 489-501, 2002.
82. Welch HC, Coadwell WJ, Stephens LR, and Hawkins PT. Phosphoinositide 3-kinase-dependent activation of Rac. FEBS Lett 546: 93-97, 2003.
83. Wymann MP and Pirola L. Structure and function of phosphoinositide 3-kinases. Biochim Biophys Acta 1436: 127-150, 1998.
84. Xu D, Rovira II, and Finkel T. Oxidants painting the cysteine chapel: redox regulation of PTPs. Dev Cell 2: 251-252, 2002.
85. Yasukawa T, Tokunaga E, Ota H, Sugita H, Martyn JA, and Kaneki M. S-nitrosylation-dependent inactivation of Akt/protein kinase B in insulin resistance. J Biol Chem 280: 7511-7518, 2005.
86. Yellaturu CR, Bhanoori M, Neeli I, and Rao GN. N-Ethyl-maleimide inhibits platelet-derived growth factor BB-stimulated Akt phosphorylation via activation of protein phosphatase 2A. J Biol Chem 277: 40148-40155, 2002.
87. Yu CX, Li S, and Whorton AR. Redox regulation of PTEN by S-nitrosothiols. Mol Pharmacol 68: 847-854, 2005.